A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson’s disease...

por Shin, Wonsuk, Lim, Kyoung Soo, Kim, Min-Kyoung, Kim, Hyun Sook, Hong, Jihwa, Jhee, Stanford, Kim, Joseph, Yoo, Sungeun, Chung, Yeon-Tae, Lee, Jae Moon, Cho, Doo-Yeoun
Publicado 2019